Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ya-Hui Hu

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Frontiers in Pharmacology|September 23, 2022
Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomaliesYue-Tao Zhao, Hao-Ran Dai, Yue Li, et al.
Cancer Causes & Control : CCC|April 1, 2024
Effects of hypertension and use of antihypertensive drugs in pregnancy on the risks of childhood cancers in TaiwanHelen T Orimoloye, Ya-Hui Hu, Noah Federman, et al.
Frontiers in Pharmacology|October 14, 2022
Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoringHong-Li Guo, Yue-Tao Zhao, Wei-Jun Wang, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|July 11, 2022
Effect of long-term valproic acid therapy on lipid profiles in paediatric patients with epilepsy: a meta-analysisHong-Li Guo, Na Dong, Feng Chen, et al.
Current Pharmaceutical Design|April 2, 2019
Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug TransportersYa-Hui Hu, Lin Zhou, Shan-Shan Wang, et al.
Frontiers in Pharmacology|October 9, 2024
Population pharmacokinetic study in children with vascular anomalies: body weight as a key variable in predicting the initial dose and dosing frequency of sirolimusLin Fan, Hong-Li Guo, Yue-Tao Zhao, et al.
Clinical Chemistry and Laboratory Medicine|July 12, 2023
From "wet" matrices to "dry" blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infantsHao-Ran Dai, Hong-Li Guo, Wei-Jun Wang, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Therapeutic Drug Monitoring for Sirolimus in Children with Vascular Anomalies: What Can We Learn from a Retrospective StudyYa-Hui Hu, Yue-Tao Zhao, Hong-Li Guo, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 14, 2012
Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseasesChih-Chin Kao, Vin-Cent Wu, Chin-Chi Kuo, et al.
Nuclear Medicine Communications|July 22, 2004
Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent stunning and the impairment of successful ablationYa-Hui Hu, Pei-Wen Wang, Shan-Tair Wang, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Frontiers in Pharmacology|September 23, 2022
Comparison of LC-MS/MS and EMIT methods for the precise determination of blood sirolimus in children with vascular anomaliesYue-Tao Zhao, Hao-Ran Dai, Yue Li, et al.
Cancer Causes & Control : CCC|April 1, 2024
Effects of hypertension and use of antihypertensive drugs in pregnancy on the risks of childhood cancers in TaiwanHelen T Orimoloye, Ya-Hui Hu, Noah Federman, et al.
Frontiers in Pharmacology|October 14, 2022
Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoringHong-Li Guo, Yue-Tao Zhao, Wei-Jun Wang, et al.
Epileptic Disorders : International Epilepsy Journal with Videotape|July 11, 2022
Effect of long-term valproic acid therapy on lipid profiles in paediatric patients with epilepsy: a meta-analysisHong-Li Guo, Na Dong, Feng Chen, et al.
Current Pharmaceutical Design|April 2, 2019
Methotrexate Disposition in Pediatric Patients with Acute Lymphoblastic Leukemia: What Have We Learnt From the Genetic Variants of Drug TransportersYa-Hui Hu, Lin Zhou, Shan-Shan Wang, et al.
Frontiers in Pharmacology|October 9, 2024
Population pharmacokinetic study in children with vascular anomalies: body weight as a key variable in predicting the initial dose and dosing frequency of sirolimusLin Fan, Hong-Li Guo, Yue-Tao Zhao, et al.
Clinical Chemistry and Laboratory Medicine|July 12, 2023
From "wet" matrices to "dry" blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infantsHao-Ran Dai, Hong-Li Guo, Wei-Jun Wang, et al.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Therapeutic Drug Monitoring for Sirolimus in Children with Vascular Anomalies: What Can We Learn from a Retrospective StudyYa-Hui Hu, Yue-Tao Zhao, Hong-Li Guo, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 14, 2012
Delayed diagnosis of primary aldosteronism in patients with autosomal dominant polycystic kidney diseasesChih-Chin Kao, Vin-Cent Wu, Chin-Chi Kuo, et al.
Nuclear Medicine Communications|July 22, 2004
Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent stunning and the impairment of successful ablationYa-Hui Hu, Pei-Wen Wang, Shan-Tair Wang, et al.
Pageof 12